Q3 2019 Investor Presentation

Reducing Mortality with PAP Therapy U.S. multicenter, population-based cohort study • Positive airway pressure therapy associated with a 62% lower risk of all-cause mortality • Death rate was twice as high for persons who did not receive positive airway pressure therapy - (24.7 vs 12.8 deaths per 1000 person years, p = 0.03) Proportion Surviving, % 100 90- 80 70- 60 0 Sleep Heart Health Study HR, 0.38 (95% CI, 0.18-0.81) PAP prescribed PAP not prescribed 5 10 15 20 Time, y Lisan et al., Association of PAP prescription with mortality in patients with obesity and severe OSA. The Sleep Heart Health Study, JAMA Otolaryngol Head Neck Surg 2019 ©2019 ResMed I Q3 2019 Investor Presentation | 50 ResMed

View entire presentation